Regal Assets Analytics

WDLangbein

About Bill Langbein

Before starting SanaCurrents, William (Bill) Langbein spent more than 20 years as a life science business journalist, with stops at California Medicine, In Vivo and Reuters Health. During that time, he wrote on genomic discoveries, the transition of the pharmaceutical companies to rely more on biologics, and the dawn of precision medicine, through which most drug developers came to recognize a one-drug-for-all approach would no longer work. One constant truth he learned is smaller companies deliver the most innovation and highest value to patients and investors. Yet because of the inherent volatility of biopharma and medical devices, small companies typically fly under the radar of investors. The emergence of precision medicine, however, reduces the volatility of small cap companies and increases the potential for strong returns. SanaCurrents was founded to identify the undervalued therapies that would benefit patients and investors the most.

Mirum Pharmaceuticals files rolling NDA for Alagille syndrome; Closing Position

By |2020-09-02T13:57:07-04:00September 2nd, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Updates|Tags: |

Just two days after it presented phase II data on [...]

SanaCurrents Closing Out 2 Positions: Assembly Bio & First Mirum Catalyst

By |2020-09-02T13:55:57-04:00August 31st, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents Updates|Tags: , |

Mirum Pharmaceuticals (NASDAQ:MIRM) and Assembly Biosciences (NASDAQ:ASMB) each presented clinical [...]

Autolus Therapeutics (AUTL) Probability Sentiment 8/31/2020

By |2020-09-09T10:03:23-04:00August 29th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

Autolus Therapeutics plc (NASDAQ:AUTL) Probability Sentiment [...]

SanaCurrents Closing Out Tricida (TCDA) As More Trial Data Appears Likely

By |2020-09-02T13:56:23-04:00August 26th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: , |

As expected, Tricida (NASDAQ:TCDA) said that on August 24 it [...]

Adverum Biotechnologies (ADVM) Probability Sentiment

By |2020-09-02T13:56:33-04:00August 22nd, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) SYMBOL Probability Sentiment [...]